United States Medical Instruments & Supplies news

16:48 28 Jul 2026

Investing.com Canada Earnings Main company 🇺🇸 United States

Becton Dickinson EVP Michael Feld sells $11,784 in BDX shares By Investing.com

Michael Feld, Executive Vice President and Chief Revenue Officer at Becton Dickinson & Co. (NASDAQ:BDX), sold 75 shares of the company's common stock for a total of $11,784, priced at $157.13 per share. This transaction was conducted on July 27, 2026, under a Rule …

BDX main company

Sharemaestro market context Price above Trend Line 52 weeks +19.7% · Next-week setup negative 33.9%

16:40 28 Jul 2026

MarketBeat Earnings Main company 🇺🇸 United States

LeMaitre Vascular (LMAT) to Announce Earnings on Tuesday

LeMaitre Vascular (LMAT) is set to release its Q2 2026 earnings on Tuesday, August 4th, with analysts forecasting EPS of $0.81 and revenue of $71.473 million. This follows a strong previous quarter where the company surpassed EPS estimates by $0.02 and saw an 11.1% …

LMAT main company

Sharemaestro market context Price below Trend Line 52 weeks -17.3% · Next-week setup positive 60.5%

16:40 28 Jul 2026

ChartMill Earnings Main company 🇺🇸 United States

Repligen (NASDAQ:RGEN) Rallies as Quality Stock Delivers Earnings Beat

Repligen (NASDAQ:RGEN) reported a significant earnings beat for Q2 2026, with non-GAAP EPS of $0.54 against an analyst consensus of $0.46, despite revenue being marginally below expectations. The stock surged over 75% in pre-market trading, recouping recent losses, as investors prioritized profitability improvements. The …

RGEN main company

Sharemaestro market context Trend signal active 52 weeks +33.7%

16:39 28 Jul 2026

Moomoo Market update Main company 🇺🇸 United States

$Pulse Biosciences (PLSE.US)$ the squeeze is onnnnnnnnn

The article is a short social media post by user Papacito on the moomoo Community platform, stating that Pulse Biosciences ($PLSE.US$) is "squeeeeezing." The post consists of a single sentence and a featured image, focusing on the potential for a short squeeze in the …

PLSE main company

Sharemaestro market context Trend signal active 52 weeks +161.2%

16:17 28 Jul 2026

Stock Titan Earnings Main company 🇺🇸 United States

Becton Dickinson (NYSE: BDX) EVP Michael Feld sells 75 shares under plan

Becton Dickinson & Co's EVP and Chief Revenue Officer, Michael Feld, sold 75 shares of common stock on July 27, 2026, at $157.13 per share. This transaction was conducted under a Rule 10b5-1 trading plan established on February 7, 2025. After the sale, Feld …

BDX main company

Sharemaestro market context Price above Trend Line 52 weeks +19.7% · Next-week setup negative 33.9%

16:09 28 Jul 2026

Investing.com South Africa Earnings Main company 🇺🇸 United States

Avantor earnings up next: Can turnaround stem market share losses? By Investing.com

Avantor Inc. is set to report its second-quarter earnings, facing skepticism from analysts due to market share losses and pricing pressures, particularly from competitors like Thermo Fisher. The market is keenly watching for signs that the company's turnaround efforts are stabilizing its competitive position …

AVTR main company

Sharemaestro market context Trend signal active 52 weeks +2.9%

15:41 28 Jul 2026

Market source Earnings Main company 🇺🇸 United States

AptarGroup (ATR) Stock Could Be Below Fair Value Following Its 15% Fall

AptarGroup (ATR) stock is showing mixed valuation signals after a 15% fall. While a Discounted Cash Flow (DCF) analysis suggests the stock is undervalued by 41.0% with an intrinsic value of $226 per share compared to its current $133.37, earnings-based multiples indicate it might …

ATR main company

Sharemaestro market context Price above Trend Line 52 weeks -5.5%

15:37 28 Jul 2026

Investing.com Canada Earnings Main company 🇺🇸 United States

Stifel raises Baxter stock price target on segment restructuring By Investing.com

Stifel increased its price target for Baxter International Inc. to $24.00 from $19.00, maintaining a Hold rating, attributing the adjustment to the company's recent segment restructuring. Baxter transitioned from three reporting segments to two, with Medical Products & Therapies now representing about 70% of …

BAX main company

Sharemaestro market context Trend signal active 52 weeks +9.8%

15:31 28 Jul 2026

CNBC Earnings Main company 🇺🇸 United States

Tuesday's move in Intuitive Surgical is probably more than short covering. How to play it using options

Intuitive Surgical (ISRG) saw a significant stock increase on Tuesday, rising 5.7% to $356.83, following an earlier drop despite beating earnings estimates. Analyst Nishant Pant suggests this rise is more than just short covering, supported by converging technical indicators like MACD and RSI, though …

ISRG main company

Sharemaestro market context Price below Trend Line 52 weeks -17.1% · Next-week setup negative 41.3%

15:25 28 Jul 2026

Fierce Pharma Regulatory and legal Main company 🇺🇸 United States

Baxter issues recall of antibiotic IV bags after bits of cardboard flagged in solution

Baxter International has voluntarily recalled one lot of cefazolin in dextrose injection after a report of cardboard contamination in an IV infusion bag. The recalled batch, LD175708, was distributed across the U.S. and poses risks such as blood vessel blockages, immune system activation, and …

BAX main company

Sharemaestro market context Trend signal active 52 weeks +9.8%

15:11 28 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

OraSure Technologies Inc (OSUR) Income Statement

This article provides a detailed income statement for OraSure Technologies Inc (OSUR), offering quarterly and annual financial performance data. It includes key metrics such as total revenue, cost of revenue, operating expenses, and net income, allowing users to analyze the company's operational efficiency and …

OSUR main company

Sharemaestro market context Trend signal active 52 weeks +28.0% · Next-week setup negative 40.2%

15:00 28 Jul 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

ISRG Q2 Earnings Call Signals Durable Demand & U.S. Caution

Intuitive Surgical, Inc. ISRG used its second-quarter 2026 earnings call to emphasize strong platform adoption while acknowledging slower U.S. procedure growth in deferrable categories. Management maintained its full-year procedure outlook, raised the gross-margin range and highlighted da Vinci 5, SP, Ion and lower-cost system …

ISRG main company

Sharemaestro market context Price below Trend Line 52 weeks -17.1% · Next-week setup negative 41.3%

14:47 28 Jul 2026

24/7 Wall St. Earnings Main company 🇺🇸 United States

Intuitive Surgical Fell 37% to $355 With This Wall Street Pro Is Calling for $685

Intuitive Surgical (ISRG) shares have fallen 37% year-to-date despite consistently beating Q2 earnings estimates, due to reduced full-year procedure growth guidance and tariff concerns. Despite this, Bernstein, the most bullish analyst, maintains a $685 target, implying 92% upside, while consensus stands at $484 for …

ISRG main company

Sharemaestro market context Price below Trend Line 52 weeks -17.1% · Next-week setup negative 41.3%

14:41 28 Jul 2026

Kalkine Media Market update Main company 🇺🇸 United States

L1 Capital Pty Ltd Executes Insider Sale of 23,000 Anteris Technologies (NASDAQ: AVR) Shares

L1 Capital Pty Ltd, a director of Anteris Technologies Global Corp. (NASDAQ: AVR), sold 23,000 shares of common stock at $8.13 per share on July 24, 2026. This transaction was disclosed on July 28, 2026, and L1 Capital still holds approximately 7.789 million shares …

AVR main company

Sharemaestro market context Trend signal active 52 weeks +126.5%

14:14 28 Jul 2026

Stock Traders Daily Market update Main company 🇺🇸 United States

How Align Technology Inc. (ALGN) Affects Rotational Strategy Timing

This article analyzes Align Technology Inc. (ALGN) using AI models to determine its impact on rotational strategy timing. It highlights weak near and mid-term sentiment but a strong long-term outlook for the stock, presenting specific entry, target, and stop-loss levels for different trading strategies. …

ALGN main company

Sharemaestro market context Price above Trend Line 52 weeks +21.2%

14:11 28 Jul 2026

AlphaStreet Deals and strategy Main company 🇺🇸 United States

Repligen Corp (RGEN) Q2 2026 Earnings Call Transcript

Repligen Corp announced strong Q2 2026 earnings, with 12% reported growth and 13% organic growth, leading to a raised full-year guidance for organic revenue and adjusted EPS. The company saw robust performance in proteins and analytics, with significant growth in APAC and emerging biotech. …

RGEN main company

Sharemaestro market context Trend signal active 52 weeks +33.7%

14:09 28 Jul 2026

TMX Newsfile Regulatory and legal Main company 🇺🇸 United States

Kaplan Fox & Kilsheimer LLP Announces an Investigation into Medline Inc. (MDLN) for Possible Securities Law Violations

Kaplan Fox & Kilsheimer LLP has initiated an investigation into Medline Inc. (MDLN) for potential securities law violations following a warning letter from the FDA. The FDA cited "significant violations of Current Good Manufacturing Practice regulations" and inadequate investigations of discrepancies and contamination incidents, …

MDLN main company

Sharemaestro market context Price below Trend Line 35 weeks -14.2% · Next-week setup negative 37.7%

14:09 28 Jul 2026

scanx.trade Earnings Main company 🇺🇸 United States

Harvard Bioscience Q2 Results: Earnings Call Set for August 11

Harvard Bioscience Inc (NASDAQ: HBIO) will release its second-quarter 2026 financial results before market open on August 11, 2026. The company will host a conference call on the same day at 8:00 AM ET to discuss its performance and business outlook. Financial materials, including …

HBIO main company

Sharemaestro market context Trend signal active 52 weeks +36.1% · Next-week setup negative 37.0%

13:58 28 Jul 2026

Investing.com Analyst action Main company 🇺🇸 United States

UBS starts medtech coverage, favors Intuitive Surgical and Enovis

UBS has initiated coverage on four U.S. medical technology companies, expressing bullish sentiments toward Intuitive Surgical and Enovis, while taking a more cautious stance on Inspire Medical Systems and a neutral view on Integra LifeSciences. The brokerage sees significant growth opportunities for Intuitive Surgical …

ISRG main company

Sharemaestro market context Price below Trend Line 52 weeks -17.1% · Next-week setup negative 41.3%

13:41 28 Jul 2026

Stock Titan Earnings Main company 🇺🇸 United States

L1 Capital sells shares of Anteris Technologies Global Corp. (NASDAQ: AVR)

L1 Capital Pty Ltd, a 10% owner of Anteris Technologies Global Corp. (NASDAQ: AVR), reported two indirect sales of the company's shares. On July 24, 2026, they sold 23,000 common shares at $8.13, and on July 27, 2026, they sold 48,344 CHESS Depository Interests …

AVR main company

Sharemaestro market context Trend signal active 52 weeks +126.5%

13:41 28 Jul 2026

Stock Titan Deals and strategy Main company 🇺🇸 United States

L1 Capital expands Anteris Technologies (AVR) stake with significant share purchases

L1 Capital Pty Ltd, holding over 10% of Anteris Technologies Global Corp. (AVR), has increased its stake through indirect open-market purchases. The firm bought 5,000,000 common shares at $5.75 on January 22, 2026, bringing its indirect common share holdings to 7,812,000. This follows a …

AVR main company

Sharemaestro market context Trend signal active 52 weeks +126.5%

13:39 28 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

Price to earnings forward of Anbio Biotechnology Class A – DUS:N3B

This page on TradingView provides a financial overview of Anbio Biotechnology Class A (DUS:N3B), specifically focusing on its forward price-to-earnings ratio. The article itself is very brief, mainly serving as a placeholder for financial data that would typically be displayed on a TradingView page. …

NNNN main company

Sharemaestro market context Price below Trend Line 52 weeks -82.5% · Next-week setup positive 59.3%

13:30 28 Jul 2026

globenewswire.com Market update Main company 🇺🇸 United States

Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship

CHARLOTTE, N.C., July 28, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona, the world's largest diversified manufacturer of professional dental products and technologies, today announced an expansion of its long-standing relationship with Medline Sinclair, one of Canada's leading full-service dental distributors. Effective September 1, 2026, Medline …

XRAY main company

Sharemaestro market context Price below Trend Line 52 weeks -18.8%

13:15 28 Jul 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

Repligen (RGEN) Beats Q2 Earnings and Revenue Estimates

Repligen (RGEN) came out with quarterly earnings of $0.54 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.37 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

RGEN main company

Sharemaestro market context Trend signal active 52 weeks +33.7%

13:11 28 Jul 2026

TradingKey Market update Main company 🇺🇸 United States

Daxor Corp (DXR) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Daxor Corp (DXR), focusing on various indicators and moving averages to assess its current market status. It details specific indicator values for MACD, RSI, KDJ, ATR, CCI, Williams %R, TRIX, and StochRSI, along with moving average values …

DXR main company

Sharemaestro market context Price below Trend Line 52 weeks -5.5%

13:10 28 Jul 2026

Stock Titan Deals and strategy Main company 🇺🇸 United States

Dental distributor Medline Sinclair will offer Dentsply Sirona tech Sept. 1

Dentsply Sirona announced an expanded partnership with Medline Sinclair, a leading Canadian dental distributor, to offer its technology portfolio across Canada starting September 1, 2026. This move is Dentsply Sirona's sixth dealer network enhancement in 2026, aiming to broaden access to digital dentistry solutions. …

XRAY main company

Sharemaestro market context Price below Trend Line 52 weeks -18.8%

13:08 28 Jul 2026

Investing.com Analyst action Main company 🇺🇸 United States

UBS initiates Intuitive Surgical stock coverage with buy rating

UBS has initiated coverage of Intuitive Surgical Inc. (NASDAQ: ISRG) with a buy rating and a price target of $500.00, citing its leadership in medical technology despite recent stock pressure. The firm believes Intuitive Surgical is undervalued at current levels, noting potential for accelerated …

ISRG main company

Sharemaestro market context Price below Trend Line 52 weeks -17.1% · Next-week setup negative 41.3%

12:50 28 Jul 2026

nasdaq.com Earnings Main company 🇺🇸 United States

Here's Exactly Why Wall Street Thinks Intuitive Surgical Stock Could Soar 102% Over the Next 12 Months

Key Points The da Vinci 5 is driving growth throughout the business. This traditionally expensive stock has suddenly become a bargain. The business hasn't lost its luster, so look for the stock to rebound.10 stocks we like better than Intuitive Surgical › Intuitive Surgical(NASDAQ: …

ISRG main company

Sharemaestro market context Price below Trend Line 52 weeks -17.1% · Next-week setup negative 41.3%

12:42 28 Jul 2026

The Globe and Mail Regulatory and legal Main company 🇺🇸 United States

Kaplan Fox Encourages Investors of Medline Inc. (NASDAQ: MDLN) to Contact the Firm Regarding Potential Securities Law Violations

Kaplan Fox & Kilsheimer LLP is investigating Medline Inc. (NASDAQ: MDLN) for potential securities law violations following a June 2, 2026 FDA warning letter citing "significant violations of Current Good Manufacturing Practice regulations" and inadequate investigation into manufacturing issues. This news led to a …

MDLN main company

Sharemaestro market context Price below Trend Line 35 weeks -14.2% · Next-week setup negative 37.7%

12:34 28 Jul 2026

GlobeNewswire Regulatory and legal Main company 🇺🇸 United States

Portnoy Law Firm Announces Class Action on Behalf of Embecta Corp. Investors

The Portnoy Law Firm has announced a class action lawsuit on behalf of Embecta Corp. (NASDAQ: EMBC) investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit alleges that Embecta made misleading statements regarding its fiscal guidance, particularly concerning weakness …

EMBC main company

Sharemaestro market context New activity signal 52 weeks -63.1%

12:27 28 Jul 2026

nasdaq.com Earnings Main company 🇺🇸 United States

Repligen Corp Bottom Line Declines In Q2

(RTTNews) - Repligen Corp (RGEN) announced a profit for second quarter that Drops, from last year The company's bottom line totaled $5.01 million, or $0.09 per share. This compares with $14.87 million, or $0.26 per share, last year. Excluding items, Repligen Corp reported adjusted …

RGEN main company

Sharemaestro market context Trend signal active 52 weeks +33.7%

12:23 28 Jul 2026

Investing.com Canada Analyst action Main company 🇺🇸 United States

UBS initiates Becton Dickinson stock coverage with buy rating By Investing.com

UBS has initiated coverage on Becton Dickinson & Co. (NYSE:BDX) with a buy rating and a price target of $190.00, citing the company's de-rated valuation and anticipated mid-single-digit long-term growth. The firm believes market concerns about slowing growth and inflation are overstated, highlighting BD's …

BDX main company

Sharemaestro market context Price above Trend Line 52 weeks +19.7% · Next-week setup negative 33.9%

12:22 28 Jul 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q2 CY2026

Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q2 CY2026 Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) reported Q2 CY2026 results topping the market's revenue expectations , with sales up 11.9% year on year to $204.1 million. The company expects the full year's revenue to be around …

RGEN main company

Sharemaestro market context Trend signal active 52 weeks +33.7%

12:13 28 Jul 2026

Quiver Quantitative Deals and strategy Main company 🇺🇸 United States

Repligen Reports Q2 2026 Revenue Growth, Raises Full-Year Organic Revenue and EPS Guidance

Repligen Corporation announced strong second-quarter 2026 financial results, with revenue reaching $204 million, marking a 12% year-over-year increase and 13% organic growth. Due to this performance and continued order momentum, the company has raised its full-year 2026 organic revenue growth guidance to 10.5%-13.5% and …

RGEN main company

Sharemaestro market context Trend signal active 52 weeks +33.7%

12:12 28 Jul 2026

Investing.com Analyst action Main company 🇺🇸 United States

Oppenheimer raises Pulse Biosciences stock price target on AF data

Oppenheimer has increased its price target for Pulse Biosciences (NASDAQ:PLSE) to $35.00 from $30.00, maintaining an Outperform rating, following positive data from the company's nsPFA EFS study on atrial fibrillation. The stock has seen a 142% surge in the past six months and is …

PLSE main company

Sharemaestro market context Trend signal active 52 weeks +161.2%

12:11 28 Jul 2026

TradingView Deals and strategy Main company 🇺🇸 United States

Repligen Reports Q2 2026: Revenue $204M, Adjusted EPS $0.54; Raises FY26 Guidance

Repligen reported strong second-quarter 2026 results with revenue of $204.1 million, a 12% year-over-year increase, and adjusted diluted EPS of $0.54. The company has raised its full-year 2026 guidance for organic revenue growth and adjusted diluted EPS, driven by continued order momentum and portfolio …

RGEN main company

Sharemaestro market context Trend signal active 52 weeks +33.7%